Emma Persson

Company: argenx BV

Job title: Scientist, Clinical

Seminars:

Safety, Efficacy, Pharmacokinetics & Pharmacodynamics of ARGX-117, a Therapeutic Antibody Targeting Complement Factor 2 12:20 pm

Evaluating how the ARGX-117 antibody has been engineered to have a long half life Demonstrating that administration of ARGX-117 in healthy volunteers is safe and well-tolerated ARGX-117 is being studied in adults with multifocal motor neuropathy in a Phase 2 clinical studyRead more

day: Track B - Day 1 AM